ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

This study is currently recruiting participants.
Verified by National Institute of Allergy and Infectious Diseases (NIAID), March 2006

Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00001137
  Purpose

The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.


Condition
HIV Infections

MedlinePlus related topics:   AIDS    AIDS Medicines   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Prospective
Official Title:   Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Protocol

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Estimated Enrollment:   4500

Detailed Description:

A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1. Using data from present and recently completed studies, this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication.

No treatment is provided by this study, but patients will continue to receive highly active antiretroviral therapy (HAART) from other studies in which they are coenrolled. Blood and urine collection will occur at study entry and periodically throughout the study. Women may undergo pelvic exams and Pap smears. Portions of blood samples will be stored to evaluate genotypic/phenotypic susceptibility testing. Medical histories, physical exams, and questionnaires will be completed periodically.

  Eligibility
Ages Eligible for Study:   13 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria

  • HIV-1 infected
  • Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this study on or before the Week 16 visit of the parent study. More information on this criterion can be found in the protocol.
  • Willing to provide consent for the release and use of clinical data from the parent study
  • Life expectancy of at least 24 weeks
  • Parent or guardian willing to provide informed consent, if applicable

Exclusion Criteria

  • Active alcohol or drug abuse that may interfere with the study
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001137

Show 65 study locations  Show 65 Study Locations

Sponsors and Collaborators

Investigators
Study Chair:     Constance A. Benson, MD     Division of Infectious Disease, Antiviral Research Center, University of California, San Diego    
Study Chair:     Ann C. Collier, MD     University of Washington, Harborview Medical Center    
  More Information

Haga clic aquí para ver información sobre este ensayo clínico en español.  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   ACTG A5001, AACTG A5001
First Received:   January 28, 2000
Last Updated:   January 2, 2008
ClinicalTrials.gov Identifier:   NCT00001137
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Treatment Experienced  
Treatment Naive  
Virus Replication  
AIDS-Related Opportunistic Infections  
HIV-1  
Risk Factors  
Incidence  
RNA, Viral
Anti-HIV Agents
Viral Load
Lipodystrophy
Nervous System
Cardiovascular System

Study placed in the following topic categories:
Virus Diseases
Opportunistic Infections
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Lipodystrophy
Acquired Immunodeficiency Syndrome
AIDS-Related Opportunistic Infections
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on August 28, 2008




Links to all studies - primarily for crawlers